Zevin Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $558K | Hold |
4,006
| – | – | 0.08% | 63 |
|
|
2025
Q4 | $492K | Hold |
4,006
| – | – | 0.07% | 68 |
|
|
2025
Q3 | $445K | Hold |
4,006
| – | – | 0.06% | 62 |
|
|
2025
Q2 | $444K | Sell |
4,006
-1,299
| -24% | -$138K | 0.06% | 57 |
|
|
2025
Q1 | $594K | Sell |
5,305
-717
| -12% | -$74K | 0.09% | 48 |
|
|
2024
Q4 | $556K | Buy |
6,022
+5
| +0.1% | +$450 | 0.08% | 51 |
|
|
2024
Q3 | $504K | Hold |
6,017
| – | – | 0.08% | 54 |
|
|
2024
Q2 | $413K | Hold |
6,017
| – | – | 0.07% | 55 |
|
|
2024
Q1 | $441K | Sell |
6,017
-20
| -0.3% | -$1.54K | 0.07% | 57 |
|
|
2023
Q4 | $489K | Buy |
6,037
+20
| +0.3% | +$1.56K | 0.09% | 59 |
|
|
2023
Q3 | $451K | Hold |
6,017
| – | – | 0.09% | 60 |
|
|
2023
Q2 | $464K | Sell |
6,017
-2,393
| -28% | -$191K | 0.09% | 56 |
|
|
2023
Q1 | $698K | Hold |
8,410
| – | – | 0.14% | 52 |
|
|
2022
Q4 | $722K | Hold |
8,410
| – | – | 0.16% | 50 |
|
|
2022
Q3 | $519K | Hold |
8,410
| – | – | 0.12% | 52 |
|
|
2022
Q2 | $520K | Hold |
8,410
| – | – | 0.12% | 55 |
|
|
2022
Q1 | $500K | Hold |
8,410
| – | – | 0.1% | 63 |
|
|
2021
Q4 | $611K | Hold |
8,410
| – | – | 0.11% | 60 |
|
|
2021
Q3 | $587K | Hold |
8,410
| – | – | 0.11% | 61 |
|
|
2021
Q2 | $579K | Hold |
8,410
| – | – | 0.12% | 61 |
|
|
2021
Q1 | $544K | Hold |
8,410
| – | – | 0.12% | 58 |
|
|
2020
Q4 | $490K | Buy |
8,410
+2,700
| +47% | +$163K | 0.12% | 60 |
|
|
2020
Q3 | $361K | Hold |
5,710
| – | – | 0.1% | 64 |
|
|
2020
Q2 | $439K | Buy |
5,710
+225
| +4% | +$17.2K | 0.13% | 54 |
|
|
2020
Q1 | $410K | Hold |
5,485
| – | – | 0.15% | 53 |
|
|
2019
Q4 | $356K | Buy |
+5,485
| New | +$357K | 0.11% | 69 |
|
|
2016
Q4 | – | Sell |
-4,400
| Closed | -$348K | – | 117 |
|
|
2016
Q3 | $348K | Sell |
4,400
-52
| -1% | -$4.22K | 0.11% | 87 |
|
|
2016
Q2 | $371K | Hold |
4,452
| – | – | 0.1% | 90 |
|
|
2016
Q1 | $409K | Buy |
4,452
+52
| +1% | +$4.69K | 0.12% | 85 |
|
|
2015
Q4 | $445K | Hold |
4,400
| – | – | 0.12% | 87 |
|
|
2015
Q3 | $432K | Sell |
4,400
-250
| -5% | -$27.8K | 0.13% | 90 |
|
|
2015
Q2 | $544K | Hold |
4,650
| – | – | 0.15% | 90 |
|
|
2015
Q1 | $456K | Sell |
4,650
-133
| -3% | -$13.5K | 0.13% | 92 |
|
|
2014
Q4 | $451K | Buy |
4,783
+133
| +3% | +$13.8K | 0.13% | 94 |
|
|
2014
Q3 | $495K | Hold |
4,650
| – | – | 0.14% | 90 |
|
|
2014
Q2 | $386K | Hold |
4,650
| – | – | 0.11% | 97 |
|
|
2014
Q1 | $329K | Hold |
4,650
| – | – | 0.1% | 90 |
|
|
2013
Q4 | $349K | Hold |
4,650
| – | – | 0.1% | 90 |
|
|
2013
Q3 | $292K | Hold |
4,650
| – | – | 0.09% | 92 |
|
|
2013
Q2 | $238K | Buy |
+4,650
| New | +$242K | 0.08% | 96 |
|
Other funds holding GILD
VCM
VPM
Zevin Asset Management's GILD Position: Q1 2026 in Review
Zevin Asset Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 4,006 shares worth $558K. The position accounts for 0.08% of the portfolio, ranked #63.
Zevin Asset Management first reported a position in GILD in Q2 2013 and has held it in 40 quarters since. The position peaked at $722K in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Zevin Asset Management held 4,006 shares of Gilead Sciences worth $558K as of Q1 2026.
- Zevin Asset Management left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.08% of Zevin Asset Management's portfolio in Q1 2026, its #63 holding.
- Zevin Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 40 quarters since.
- Zevin Asset Management's Gilead Sciences position peaked at $722K in Q4 2022.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Zevin Asset Management's 13F filing for Q1 2026, filed 7 May 2026.